Market Closed -
Euronext Paris
10:30:25 2024-02-29 am EST
|
5-day change
|
1st Jan Change
|
12
EUR
|
-4.00%
|
|
-.--%
|
-17.81%
|
Fiscal Period: December |
2016
|
2017
|
2019
|
2020
|
2021
|
---|
Capitalization
1 |
41.74
|
39.42
|
34.78
|
34.78
|
34.78
|
Enterprise Value (EV)
1 |
45.15
|
46.26
|
40.39
|
40.16
|
34.98
|
P/E ratio
|
-134
x
|
-19.7
x
|
-
|
-69
x
|
44.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
65.8
x
|
27.6
x
|
219
x
|
6,626
x
|
67,022
x
|
EV / Revenue
|
71.1
x
|
32.4
x
|
254
x
|
7,650
x
|
67,400
x
|
EV / EBITDA
|
-51.4
x
|
-33.3
x
|
-21.3
x
|
-36.9
x
|
-47.3
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.87
x
|
4.49
x
|
-
|
2.37
x
|
2.25
x
|
Nbr of stocks (in thousands)
|
2,319
|
2,319
|
2,319
|
2,319
|
2,319
|
Reference price
2 |
18.00
|
17.00
|
15.00
|
15.00
|
15.00
|
Announcement Date
|
7/10/17
|
8/2/18
|
10/19/21
|
10/19/21
|
8/8/22
|
Fiscal Period: December |
2016
|
2017
|
2019
|
2020
|
2021
|
---|
Net sales
1 |
0.6347
|
1.429
|
0.1589
|
0.00525
|
0.000519
|
EBITDA
1 |
-0.8778
|
-1.389
|
-1.9
|
-1.087
|
-0.7396
|
EBIT
1 |
-1.032
|
-1.691
|
-2.515
|
-1.243
|
-0.7948
|
Operating Margin
|
-162.52%
|
-118.32%
|
-1,583%
|
-23,673.7%
|
-153,134.49%
|
Earnings before Tax (EBT)
1 |
-0.3108
|
-1.999
|
8.674
|
-0.5037
|
0.7791
|
Net income
1 |
-0.3111
|
-1.999
|
8.674
|
-0.5039
|
0.7766
|
Net margin
|
-49.02%
|
-139.87%
|
5,459.47%
|
-9,597.79%
|
149,633.53%
|
EPS
2 |
-0.1342
|
-0.8622
|
-
|
-0.2173
|
0.3349
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/10/17
|
8/2/18
|
10/19/21
|
10/19/21
|
8/8/22
|
Fiscal Period: December |
2016
|
2017
|
2019
|
2020
|
2021
|
---|
Net Debt
1 |
3.41
|
6.84
|
5.61
|
5.38
|
0.2
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-3.885
x
|
-4.923
x
|
-2.951
x
|
-4.947
x
|
-0.2651
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-5.33%
|
-20.4%
|
-
|
-3.38%
|
5.16%
|
ROA (Net income/ Total Assets)
|
-6.32%
|
-6.19%
|
-
|
-3.65%
|
-2.56%
|
Assets
1 |
4.924
|
32.28
|
-
|
13.81
|
-30.37
|
Book Value Per Share
2 |
4.650
|
3.790
|
-
|
6.320
|
6.650
|
Cash Flow per Share
2 |
0.7000
|
0.1500
|
-
|
0
|
0.0200
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
7/10/17
|
8/2/18
|
10/19/21
|
10/19/21
|
8/8/22
|
|
1st Jan change
|
Capi.
|
---|
| -17.81% | 30.35M | | -22.15% | 12.06B | | -53.95% | 2.1B | | -27.75% | 1.2B | | -.--% | 1.12B | | +99.49% | 534M | | +39.87% | 515M | | +27.37% | 279M | | -13.97% | 197M | | +2.96% | 186M |
Medical Imaging Systems
|